InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by COELHO PHILIP H, Director. Director active across 2 companies, notably Ampio Pharmaceuticals, Inc.. In total, 6 disclosures have been recorded. The latest transaction was disclosed on 24 August 2021 — Levée d'options. Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
1,333 shares
Common Stock, par value $0.001 per share
SEC:0001161697-21-000549·
1,333 shares
Common Stock, par value $0.001 per share
SEC:0001161697-21-000549:0·
€44,24516,667 shares@ €2.65460.0012% mcap100.0% of flow
Common stock, par value $0.001 per share
SEC:0001161697-21-000408·
€44,24516,667 shares@ €2.65460.0012% mcap50.0% of flow
Common stock, par value $0.001 per share
SEC:0001161697-21-000408:0·
€2,2046,737 shares@ €0.32721.06% mcap100.0% of flow
Common Stock
SEC:0001415889-21-002666·
€2,2046,737 shares@ €0.32721.06% mcap50.0% of flow
Common Stock
SEC:0001415889-21-002666:0·
6 of 6 declarations
About COELHO PHILIP H
Philip H. Coelho is a Board Member at Ampio Pharmaceuticals, Inc. and CATALYST PHARMACEUTICALS, INC. In this role, he contributes to corporate governance and strategic decision-making. Philip H. Coelho brings his expertise in biopharmaceuticals, enabling him to guide the board in achieving the company's objectives. His commitment to innovation and quality is essential for the company's development.
